|
Kerala, known for its vibrant diaspora, has become a focal point for the early identification of rare infections. The state's significant NRI population, estimated at 22 lakh, with many working in Gulf countries and pursuing education abroad, contributes to this phenomenon. This was evident during the 2020 Covid-19 wave, where numerous cases emerged among returning NRIs, triggered by a student returning from China. The widespread presence of Malayalis globally compels the state's health sector to remain vigilant against emerging diseases.
While the Kerala health department emphasizes airport screening implemented after the WHO declared Mpox a public health emergency, experts point out its limitations. Basic screenings at airports are only effective in high-alert situations. Dr. S.S. Lal, a public health expert and former technical officer of WHO, highlights the role of Kerala's high health awareness and its robust network of hospitals, including private facilities, in facilitating early diagnosis. The expertise of its medical professionals further contributes to the state's ability to identify unusual infections.
The case of Mpox exemplifies the interplay of factors contributing to Kerala's early detection. The infected individual demonstrated self-awareness and preventive measures by isolating himself from family members, leading to prompt medical attention. Similarly, numerous Nipah and amoebic meningoencephalitis cases were first diagnosed at private hospitals in Kerala. The state's healthcare system, with its advanced facilities and skilled professionals, has also facilitated the recovery of many individuals with rare infections. These attributes collectively highlight the strengths of Kerala's health sector and its role in effectively managing emerging health challenges.